Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials
Tran, Tram T., Mehta, Darshan, Mensa, Federico, Park, Caroline, Bao, Yanjun, Sanchez Gonzalez, YuriLanguage:
english
Journal:
Infectious Diseases and Therapy
DOI:
10.1007/s40121-018-0218-x
Date:
October, 2018
File:
PDF, 1.17 MB
english, 2018